Mei Luo Pharmaceutical denied that the introduction of bee venom products Tasly denied the overall listing
Mei Luo Pharmaceutical denied launching bee venom products
Recently, U.S. experts said that acne-killing toxins can kill HIV, and Meiluo Pharmaceutical (600297) has been reported to have launched its high-quality products bee venom injection and ginseng glycopeptide. Affected by this news, the stock yesterday sealed the daily limit after ten minutes of opening, and finally closed at 7.52 yuan. However, the company issued a clarification announcement late yesterday.
Recently, there are articles saying that Matsubara Merrill Pharmaceuticals Co., Ltd. (hereinafter referred to as “Miro Matsubaraâ€), which has produced bee venom and other related products, is associated with Merrill Pharmaceuticals. This is the evidence that Mei Luo Pharmaceutical has launched bee venom products.
Yesterday evening, Mei Luo Pharmaceutical announced that the company did not have bee venom injection products and related components of the product, "the company's holding subsidiaries, branches and joint ventures have not produced bee venom related products." For Matsubara Mir According to the rumor, Mei Luo Pharmaceutical stated that it had transferred all of its 60% equity interest in Song Luo's Mei Luo on June 19, 2007. After the completion of the transfer, the company did not have any affiliated relationship with the company.
Wolong Real Estate Net Profit Drops Nearly 50%
Wolong Real Estate (600173) released its results yesterday, said that in 2012, the company achieved operating income of 7671.661 million yuan, operating profit of 91,690,800 yuan, attributable to the shareholders of listed companies net profit of 74,245,400 yuan, a year-on-year decrease of 47.36%; attributable to the shareholders of listed companies Net assets per share was 1.98 yuan, a decrease of 4.35% from the same period last year.
According to the report, Wolong Real Estate's operating income decreased by 22.82% compared with that of 2011, mainly due to the impact of real estate macro-control. Buyers are more likely to wait and see in the atmosphere, leading to a substantial reduction in operating income as compared with the same period in 2011. The gross profit rate of its real estate business decreased by 4.4% year-on-year, which was mainly due to the different product mix of price discount promotion and carry-over income. In addition, due to the increase in the company’s borrowings at this level, the financial expenses increased by 111.84% year-on-year.
The announcement revealed that at the end of the reporting period, the company had a land bank with a floor area of ​​approximately 2,509,700 square meters.
Jinzhou Port's profit fell by nearly 50% last year
Yesterday, Jinzhou Port (600190) released its 2012 annual report, showing that the net profit attributable to shareholders of listed companies last year was 131 million yuan, which was a decrease of 47.57% compared with the previous year.
This performance report shows that due to the international and domestic economic downturn, 2012 is the most serious year for Jinzhou Port in the past 10 years. The port faces dual pressures from the market and funds. “The structural contradictions of port supply are still outstanding. The decline in coal supply has a greater impact on port throughput and income. Other types of goods are limited by the slow increase in the development of the hinterland economy, and the space for the growth of container supply has been severely squeezed.†This explains that with the increase in the investment in the company's port construction and joint venture cooperation projects, depreciation and financial expenses have increased substantially.
The previous announcement issued by Jinzhou Port indicated that due to the company's plan for non-public issuance of stocks, there is significant uncertainty, so it is currently in suspension and will resume trading today.
Tasly Denies "Overall Listing"
Recently, media reports said that Yan Xijun, chairman of Tasly Pharmaceutical Group Co., Ltd., said in an interview that the group is about to start the process of injecting chemical drugs into listed companies. However, yesterday Tasly (600,535) issued an announcement stating that the company has never had a "holistic listing" plan and arrangement.
Tasly responded that the company's controlling shareholder, Tianjin Tianshili Pharmaceutical Group Co., Ltd., is a diversified group company with a major health industry as the main line. The business involves modern Chinese medicines manufacturing, chemical medicine, biopharmaceuticals, medical industry, health products, health foods and other extensive fields. . After verifying it, Tasly Group has never had an overall listing plan and arrangement.
Tasly's share price slightly fell 0.04% yesterday to close at 66.52 yuan per share.
The Channel girder is a cost-effective solution for short to medium span structures. The top deck can be manufactured with a variety of traction profiles, eliminating the need for field applied wearing surfaces. Standard Channel Beam sizes are listed below in 20", 24", 28", 32" and 36" depths, but custom sizes and adaptations such as extended flanges or 2nd cast curbs are easily attainable. While the Channel Beam section was originally developed for bridges, it is also popular for marine pier, building and garage applications.
Channel Girder,Channel Girder Mould,Double Overhead Mould,Precast Channel Girder
Anshan Lijian Engineering Group Co. LTD , https://www.lijianformwork.com